Torrent Pharma (UK) Ltd. (TP-UK) is a wholly owned subsidiary of Torrent Pharmaceuticals Limited, a global pharmaceutical company specialising in the manufacture and distribution of generic pharmaceutical medicines.
Vacancy of Product Management Executive in Torrent Pharma at Ahmedabad. Thursday, December 3, 2020. Torrent Pharma is active in the therapeutic areas of Cardiovascular (CV), central nervous system (CNS), gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments.
TP-UK is a rapidly growing pharmaceutical company with an increasingly strong market presence within the UK market, operating within retail pharmacy, wholesale and hospital sectors. TP-UK stands on the principles of providing high quality prescriptive medicines at an affordable price.
Torrent Pharma Product Portfolio Example
Our focus is to expand an ever-increasing product portfolio through group development of key pharmaceutical molecules and key partner arrangements, across a range of therapies with particular focus on the treatment areas affecting the cardiovascular and central nervous system.
The Company, internationally, is ranked amongst the leaders in the therapeutic segments of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective, pain management, gynecology and pediatric segments. Recently it has been expanding it's presence in the therapeutic segments of oncology and rheumatology.
Torrent Pharma Global
Torrent Pharma's competitive advantage stems from its world-class manufacturing facilities, advanced R&D capabilities, extensive domestic network and a widespread global presence in over 40 countries.
UNITED STATES OF AMERICA
Torrent Pharma Nj
The world’s largest market for pharmaceuticals, USA has always been on Torrent Pharma’s strategic radar. Torrent Pharma Inc., our subsidiary, serves the growing need of our products in the market and today we are ranked 10th amongst the US generic Indian Companies.
We have 88 ANDAs approval with 42 approvals in pipeline. We aim to strengthen our position in the market by launching complex generics which include specialty oral solids (Oncology) and value added medicines 505(b)(2) in the coming times.
San Pharma Products
Torrent has strengthened the US presence through acquisition of Bio-Pharm, Inc. (BPI) a generic pharmaceuticals and OTC Company, based in Levittown Pennsylvania, USA, which includes, its first overseas US FDA registered manufacturing facility.